The impact of coronary heart disease in determining use of hormone replacement therapy in a general practice population

International Journal of Clinical Practice

Volumn 55, Issue 8, 2001, Pages 515-518

  Chin, Bsp ^a   Futaba, K ^a   Jethwa, A ^a   Lip, Gyh ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; SEX HORMONE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; COMPUTER SYSTEM; CONTROLLED STUDY; DIABETES MELLITUS; DRUG CONTRAINDICATION; DRUG INDICATION; ESTROGEN DEFICIENCY; FEMALE; GENERAL PRACTICE; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAMMOGRAPHY; POPULATION; POSTMENOPAUSE OSTEOPOROSIS; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZATION; RISK FACTOR; SMOKING HABIT; SYMPTOM; UNITED KINGDOM; URBAN AREA; UTERINE CERVIX CYTOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CASE-CONTROL STUDIES; CORONARY DISEASE; FAMILY PRACTICE; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; POSTMENOPAUSE; RISK FACTORS;

EID: 0034766355     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Edmunds E, Lip GYH. Cardiovascular risk in women: the cardiologist's perspective. Q J Med 2000; 93: 135-145.
2. Kuller LH, Meilahn EN, Cauley JA et al. Epidemiologic studies of menopause: changes in risk factors and disease. Exp Gerontol 1994; 29: 495-509.
3. Barrett-Connor E. Bush TL. Estrogen and Coronary Heart Disease. JAMA 1991:265:1861-1867.
4. Grodstein F, Stampfer MJ, Colditz GA el at. Postmenopausal hormone replacement therapy and mortality. N Engl J Med 1997; 336: 1769-1775.
5. Grady D, Rubin SM, Petitti DB et al. Hormone replacement therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016-1037.
6. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 1995; 273: 199-208.
7. Hulley S. Grady D, Bush T et al. Randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 154: 1333-1339.
8. Barrat-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991; 115: 455-456.
9. Dunne FP, Sadler GJ. Crampton JA. Hormone replacement therapy: why are general practitioners not prescribing more? Int J Clin Pract 1998; 52(5): 285-288.
10. Eiken P, Kolthoff N, Nielsen SP. Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women. Bone 1996; 19: 19IS-193S.
11. Lancaster T. Surman G, Lawrence M et al. Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records. J Epidemiol Comm Health 1995: 49: 389-394.
12. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: Framingham study. Ann Intern Med 1979; 85: 447-452.
13. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease: Framingham Study. Ann Intern Med 1978; 89: 157-161.
14. Tunstall-Pedoe H. Myth and paradox of coronary risk and the menopause. Lancet 1998; 351: 1425-1427.
15. Heller RF, Jacobs HS. Coronary heart disease in relation to age, sex and the menopause. BMJ 1978; 1: 472-474.
16. MRC General Practice Research Framework. Randomised comparison of oestrogen versus oestrogen plus progesterone hormone replacement therapy in women with hysterectomy. BMJ 1996; 312: 473-478.
17. Lip GYH, Blann A, Jones AF, Beevers DG. Effects of hormone replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis. Am Heart J 1997; 134: 764-771.
18. Lydakis C, Kerr H, Hutchings K, Lip GYH. Women's awareness of, and attitudes towards, hormone replacement therapy: ethnic differences and effects of age and education. Im J Clin Pract 1998; 52(1): 7-12.
19. Haskell SG, Richardson ED, Horwittz RI. The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature. J Clin Epidemiol 1997; 50: 1249-1264.
20. Grady D, Hulley SB. Hormones to prevent cronary disease in women: when are observational studies adequate evidence? Ann Intern Med 2000; 33:999-1001.